Related Experiment Videos

Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants

Insights

The new cephalosporin HR 810 did not select for beta-lactam-resistant bacteria in Enterobacter cloacae. This is likely due to its low affinity for the bacterial beta-lactamase enzyme.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Beta-lactam antibiotics are crucial for treating bacterial infections.
  • The emergence of beta-lactam resistance in bacteria like Enterobacter cloacae is a significant clinical concern.
  • Understanding the mechanisms of resistance selection is vital for developing effective antimicrobial strategies.

Purpose of the Study:

  • To investigate the potential of the novel cephalosporin HR 810 to select for beta-lactam-resistant subpopulations in Enterobacter cloacae.
  • To compare the resistance selection potential of HR 810 with other established cephalosporins.
  • To elucidate the role of bacterial beta-lactamase affinity in resistance selection.

Main Methods:

  • Culturing a clinical Enterobacter cloacae isolate (2240/81) with a 20-fold minimal inhibitory concentration of various cephalosporins for 16 hours.
  • Monitoring the levels of antibacterial agents in the culture medium to assess degradation.
  • Determining the affinity of different cephalosporins to the chromosomally mediated beta-lactamase of E. cloacae using enzyme kinetics (Ki values).

Main Results:

  • Beta-lactam resistant subpopulations did not emerge in E. cloacae when cultured with HR 810, unlike with cefoperazone, cefotaxime, ceftriaxone, and ceftazidime.
  • Antibacterial agent breakdown in the medium did not account for the lack of resistance selection.
  • HR 810 exhibited significantly low affinity (Ki = 4.4 x 10(-3)M) to the E. cloacae beta-lactamase.

Conclusions:

  • The novel cephalosporin HR 810 demonstrates a reduced capacity to select for beta-lactam-resistant subpopulations in Enterobacter cloacae.
  • The low affinity of HR 810 to the E. cloacae beta-lactamase is a key factor contributing to its inability to select for resistance.
  • These findings suggest HR 810 may offer an advantage in clinical settings by potentially minimizing the development of antibiotic resistance.

Related Concept Videos